Thrombosis UK has been awarded the global 'Activity of the Year' award from World Thrombosis Day (WTD) and the International Society on Haemostasis and Thrombosis (ISTH)
August 2021
In collaboration with the Institute of Clinical Science and Technology, Prof Beverley Hunt OBE discusses current understanding in a series of topics.
![NICE (National Institute for Health and Care Excellence) publish updated Quality Standard [QS201] for VTE in adults. Published August 2021](/admin/resources/thrombosisuk-nice-vte-aug21.jpg)
This quality standard covers reducing the risk of venous thromboembolism (VTE) in people aged 16 and over who are in hospital. It also covers diagnosing and treating VTE in all people aged 18 and over. It describes high-quality care in priority areas for improvement.
A case report published in the Annals of Internal Medicine looks at a single case of thrombocytopenia with thrombosis syndrome (TTS) after receiving the Moderna COVID-19 vaccine.
Thrombosis UK has sent a letter to Dr June Raine CBE, CEO of MHRA, expressing our concern regarding wording in the MHRA guidance on the use of the AstraZeneca COVID-19 vaccine.
Read the Letter
NHS England initiative appoints Dr Strathdee to lead national network of psychological support to all those affected by vaccine-induced thrombocytopenia and thrombosis (VITT).
Read the Letter
Schoolchildren stand up for St Annes man Louis who died suddenly aged just 24
National Institute for Health and Care Excellence has published its new shared decision making guideline.
In people with severe disease, particularly those ill enough to need hospitalisation, activation of the body’s defence results in a marked inflammatory reaction that affects the blood clotting and blood vessels, resulting in blood clots or thrombosis. These blood clots mainly affect the veins and are called venous thromboembolism or VTE.
Universal Hospital Birmingham are looking for voluntary VTE Link Practitioners from each area within the UHB trust.
Page 1 of 13
Next